We are evaluating the impact of IM student chiefs' review sessions on students' performance and satisfaction with their OSCE (observed standardized clinical evaluation) during their Medicine clerkship through a post-OSCE survey

We want to understand how young adults who vape and have depression feel about messages that encourage them to stop vaping. We're doing this to see if these messages could help people quit vaping and improve their mental health.

The purpose of this study is to understand more about the evolving practices of evangelical contemporary worship and perceptions of such practices by church leaders versus worship participants.

Patients unable to participate in decision-making about their care deserve a surrogate decision-maker to act on their behalf. In this study we will examine typical patterns employed by trainees to identify surrogates and communicate basic understanding of the surrogate role.

We are hoping to have patient who under went doulbe-jaw surgery for obstructive sleep apnea fill out a survey to inform of us there experience, expectations, and results after surgery.

This clinical trial aims to understand how well ALXN-C5IT works over a long time. We want to see if it can prevent relapses and help with disability, walking, and vision. We also want to know how patients feel about their health while using ALXN-C5IT.

This is a clinical research study to learn more about a drug being developed to treat Non segmental vitiligo. The study drug is called 'Ritlecitinib.' We wanted to learn more about how this study drug affects those with Non segmental vitiligo.

To better understand the impact of UNC's Bridge the Gap program.

Purpose: This exploratory study aims to examine characteristics and patterns of victimization experiences and protective factors during youth through the life history calendar (LHC) method with a sample of young adults. Participants: This study will recruit 25 young adults (ages 18-24) who are of a racial or ethnic minoritized identity. Potential participants must also endorse experiencing at least two victimizations prior to the age of 18 that occurred over two months in duration and at least one victimization experience rated as having had a moderately severe impact on the individual. Procedures: Participants will retrospectively reflect on their victimization experiences (onset, duration, perceived severity of impact) and perceived protective factors during childhood and early adolescence (< 18 years old) through the completion of an LHC interview.

A Phase IV, multicenter, randomized, open label trial to evaluate the effectiveness of inclisiran + usual care vs usual care alone as a tool to close care gaps within a pragmatic framework in an inclusive and underrepresented population at high risk for or diagnosed with ASCVD.